Observational Study on Chronic Myeloid Leukemia Patients in Any Phase Treated With Ponatinib (Iclusig®) at Any Dose
about
Observational Study on Chronic Myeloid Leukemia Patients in Any Phase Treated With Ponatinib (Iclusig®) at Any Dose
description
clinical trial
@en
klinisch onderzoek
@nl
name
Observational Study on Chronic ...... natinib (Iclusig®) at Any Dose
@en
type
label
Observational Study on Chronic ...... natinib (Iclusig®) at Any Dose
@en
prefLabel
Observational Study on Chronic ...... natinib (Iclusig®) at Any Dose
@en
P1050
P1476
Observational Study on Chronic ...... natinib (Iclusig®) at Any Dose
@en
P1813
Ponderosa
@en
P3098
NCT03933852
P4844
P580
2015-07-08T00:00:00Z
P582
2022-12-31T00:00:00Z